1. Home
  2. SII vs INMD Comparison

SII vs INMD Comparison

Compare SII & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
  • INMD
  • Stock Information
  • Founded
  • SII 2008
  • INMD 2008
  • Country
  • SII Canada
  • INMD Israel
  • Employees
  • SII N/A
  • INMD N/A
  • Industry
  • SII Finance: Consumer Services
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SII Finance
  • INMD Health Care
  • Exchange
  • SII Nasdaq
  • INMD Nasdaq
  • Market Cap
  • SII 1.1B
  • INMD 1.3B
  • IPO Year
  • SII N/A
  • INMD 2019
  • Fundamental
  • Price
  • SII $44.86
  • INMD $17.98
  • Analyst Decision
  • SII
  • INMD Buy
  • Analyst Count
  • SII 0
  • INMD 5
  • Target Price
  • SII N/A
  • INMD $22.25
  • AVG Volume (30 Days)
  • SII 146.2K
  • INMD 1.3M
  • Earning Date
  • SII 05-07-2025
  • INMD 05-01-2025
  • Dividend Yield
  • SII 2.67%
  • INMD N/A
  • EPS Growth
  • SII 19.38
  • INMD N/A
  • EPS
  • SII 1.91
  • INMD 2.25
  • Revenue
  • SII $178,655,000.00
  • INMD $394,818,000.00
  • Revenue This Year
  • SII N/A
  • INMD $1.92
  • Revenue Next Year
  • SII $8.66
  • INMD $5.31
  • P/E Ratio
  • SII $23.48
  • INMD $8.04
  • Revenue Growth
  • SII 18.03
  • INMD N/A
  • 52 Week Low
  • SII $37.61
  • INMD $14.87
  • 52 Week High
  • SII $48.00
  • INMD $20.98
  • Technical
  • Relative Strength Index (RSI)
  • SII 56.74
  • INMD 44.78
  • Support Level
  • SII $42.77
  • INMD $17.25
  • Resistance Level
  • SII $45.90
  • INMD $18.68
  • Average True Range (ATR)
  • SII 1.20
  • INMD 0.66
  • MACD
  • SII 0.09
  • INMD -0.09
  • Stochastic Oscillator
  • SII 76.26
  • INMD 39.72

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: